MMC
58
-2
BF.B
43
-7
TRV
64
2
GME
63
12
PGR
68
3
HBI
62
4
ISRG
68
-3
SYF
65
-6
TAP
45
-6
RF
51
-2
UPS
55
-6
CVS
45
-4
CFG
38
-2
TDC
59
10
NTAP
60
2
COST
56
3
VNO
57
-2
ADI
59
-2
RRC
56
4
EMR
57
-3
MMC
58
-2
BF.B
43
-7
TRV
64
2
GME
63
12
PGR
68
3
HBI
62
4
ISRG
68
-3
SYF
65
-6
TAP
45
-6
RF
51
-2
UPS
55
-6
CVS
45
-4
CFG
38
-2
TDC
59
10
NTAP
60
2
COST
56
3
VNO
57
-2
ADI
59
-2
RRC
56
4
EMR
57
-3
Financhill
Back

BMO Covered Call Canadian Banks ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
59

ZWB.TO
BMO Covered Call Canadian Banks ETF

Last Price:
19.40
Seasonality Move:
0.77%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
59
BMO Covered Call Canadian Banks ETF (ZWB.TO) is a Buy

Is BMO Covered Call Canadian Banks ETF a Buy, Sell or Hold?

  • The current BMO Covered Call Canadian Banks ETF [ZWB.TO] share price is $19.40. The Score for ZWB.TO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ZWB.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ZWB.TO Stock Price Chart

What is BMO Covered Call Canadian Banks ETF's stock price today?

  • The BMO Covered Call Canadian Banks ETF share price today is $19.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZWB.TO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ZWB.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 82.77 Buy
Chaikin Money Flow: 61913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.39 - 19.13) Buy
Bollinger Bands (100): (17.51 - 18.57) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ZWB.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.22 Buy
20-day SMA: 18.87 Buy
50-day SMA: 18.35 Buy
200-day SMA: 17.89 Buy
8-day EMA: 19.2 Buy
20-day EMA: 18.91 Buy
50-day EMA: 18.48 Buy
200-day EMA: 17.96 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

BMO Covered Call Canadian Banks ETF Earnings Growth & ZWB.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

BMO Covered Call Canadian Banks ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):